---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293663860.md"
description: "Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance."
datetime: "2026-07-23T20:26:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293663860.md)
  - [en](https://longbridge.com/en/news/293663860.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293663860.md)
generator: "portal-rs"
---

# 

Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.

### Related Stocks

- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Elevation Point Wealth Partners LLC Invests $1.66 Million in Edwards Lifesciences Corporation $EW](https://longbridge.com/en/news/296755573.md)
- [Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years](https://longbridge.com/en/news/296380036.md)
- [BOK Financial Private Wealth Inc. Acquires Shares of 12,115 Edwards Lifesciences Corporation $EW](https://longbridge.com/en/news/296316664.md)
- [UPDATE -- Helium Evolution Closes $25 Million Private Placement](https://longbridge.com/en/news/296948264.md)
- [Brightlands Venture Partners portfolio firm Vivalyx Omnisol wins EMA breakthrough device status](https://longbridge.com/en/news/297141130.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**